LCMV gp33-41

LCMV GP (61-80)

WDR5 inhibitor 41

Disperse Orange 41

Antibiotic K 41, monosodium salt

C.I.Reactive Yellow 41

2,5-Anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-({4-[3-(4-{1-[(2S,3S)-2-hydroxy-3-pentanyl]-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl}phenyl)-1-imidazolidinyl]phenoxy}methyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol

N-(3-fluoro-4-methylphenyl)-2-((2-(4-methoxyphenyl)quinolin-4-yl)oxy)acetamide

2-((2-(4-methoxyphenyl)quinolin-4-yl)oxy)-N-(o-tolyl)acetamide

N-(2-ethoxyphenyl)-2-((2-(4-methoxyphenyl)quinolin-4-yl)oxy)acetamide

Ethyl 4-(2-((3,4-difluorophenyl)amino)-2-oxoethoxy)-2-(3-methoxyphenyl)quinoline-6-carboxylate

Ethyl 4-(2-(mesitylamino)-2-oxoethoxy)-2-(3-methoxyphenyl)quinoline-6-carboxylate

Ethyl 2-(3-methoxyphenyl)-4-(2-oxo-2-(m-tolylamino)ethoxy)quinoline-6-carboxylate

5-ethyl-7-(4-(2-phenoxypropanoyl)piperazine-1-carbonyl)-2-phenyl-2H-pyrazolo[4,3-c]pyridin-3(5H)-one

Ethyl 4-{2-[(2-methoxyphenyl)amino]-2-oxoethoxy}-2-phenylquinoline-6-carboxylate

Ethyl 4-(2-oxo-2-((3-(trifluoromethyl)phenyl)amino)ethoxy)-2-phenylquinoline-6-carboxylate

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(6-fluoro-2-phenylquinolin-4-yl)oxy]acetamide